Growing community of inventors

Irvine, CA, United States of America

Dario G Gomez

Average Co-Inventor Count = 6.80

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 142

Dario G GomezTodd M Heidelbaugh (14 patents)Dario G GomezMichael E Garst (13 patents)Dario G GomezKen Chow (13 patents)Dario G GomezPhong X Nguyen (13 patents)Dario G GomezDaniel W Gil (11 patents)Dario G GomezLarry Allen Wheeler (7 patents)Dario G GomezWenkui Ken Fang (6 patents)Dario G GomezSantosh C Sinha (6 patents)Dario G GomezJohn E Donello (4 patents)Dario G GomezJohn R Cappiello (3 patents)Dario G GomezJames A Burke (1 patent)Dario G GomezStephen A Munk (1 patent)Dario G GomezDale A Harcourt (1 patent)Dario G GomezDaniel Gill (1 patent)Dario G GomezDaniel W Gil Gil (0 patent)Dario G GomezJohn E Donello Donello (0 patent)Dario G GomezDario G Gomez (15 patents)Todd M HeidelbaughTodd M Heidelbaugh (59 patents)Michael E GarstMichael E Garst (212 patents)Ken ChowKen Chow (124 patents)Phong X NguyenPhong X Nguyen (48 patents)Daniel W GilDaniel W Gil (84 patents)Larry Allen WheelerLarry Allen Wheeler (76 patents)Wenkui Ken FangWenkui Ken Fang (44 patents)Santosh C SinhaSantosh C Sinha (43 patents)John E DonelloJohn E Donello (136 patents)John R CappielloJohn R Cappiello (7 patents)James A BurkeJames A Burke (49 patents)Stephen A MunkStephen A Munk (9 patents)Dale A HarcourtDale A Harcourt (4 patents)Daniel GillDaniel Gill (3 patents)Daniel W Gil GilDaniel W Gil Gil (0 patent)John E Donello DonelloJohn E Donello Donello (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Allergan, Inc. (15 from 2,285 patents)


15 patents:

1. 9849113 - Methods of treating α adrenergic mediated conditions

2. 9623006 - Methods of treating α adrenergic mediated conditions

3. 9572792 - Coumarin compounds as receptor modulators with therapeutic utility

4. 9073888 - Coumarin compounds as receptor modulators with therapeutic utility

5. 9034910 - Methods of treating alpha adrenergic mediated conditions

6. 8329918 - Selective alpha 2B/2C agonists

7. 8071635 - 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazole-2-ones and related compounds

8. 8071636 - Methods of treating alpha adrenergic mediated conditions

9. 8063087 - 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds

10. 8063231 - Methods of treating alpha adrenergic mediated conditions

11. 7829587 - Substituted 2-aminotetralin derivatives as selective alpha 2B agonist

12. 7419994 - 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compounds

13. 7345077 - 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds

14. 7091232 - 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds

15. 6841684 - Imidiazoles having reduced side effects

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/4/2026
Loading…